KASH PETER M 4
4 · Nile Therapeutics, Inc. · Filed Jul 28, 2010
Insider Transaction Report
Form 4
KASH PETER M
Director
Transactions
- Award
Stock Option (Right to Buy)
2010-07-26+80,000→ 80,000 totalExercise: $0.37From: 2011-07-26Exp: 2020-07-26→ Common Stock (80,000 underlying)
Holdings
- 24,704
Warrant (Right to Buy)
Exercise: $1.25From: 2009-07-07Exp: 2014-07-07→ Common Stock (24,704 underlying) - 60,000
Stock Option (Right to Buy)
Exercise: $4.50Exp: 2018-01-25→ Common Stock (60,000 underlying) - 496,589(indirect: By Spouse)
Common Stock
- 1,596,208
Common Stock
- 165,530(indirect: By Foundation)
Common Stock
- 80,000
Stock Option (Right to Buy)
Exercise: $1.77From: 2010-07-21Exp: 2019-07-21→ Common Stock (80,000 underlying) - 24,703
Warrant (Right to Buy)
Exercise: $1.71From: 2009-07-07Exp: 2014-07-07→ Common Stock (24,703 underlying) - 35,000
Stock Option (Right to Buy)
Exercise: $0.93From: 2010-01-01Exp: 2018-12-22→ Common Stock (35,000 underlying) - 1,052
Warrant (Right to Buy)
Exercise: $2.71From: 2007-09-17Exp: 2011-09-17→ Common Stock (1,052 underlying) - 125,000
Warrant (Right to Buy)
Exercise: $1.38From: 2009-07-15Exp: 2019-07-15→ Common Stock (125,000 underlying) - 49,407
Warrant (Right to Buy)
Exercise: $2.28From: 2009-07-07Exp: 2014-07-07→ Common Stock (49,407 underlying)
Footnotes (2)
- [F1]Held by the Reporting Person's spouse as custodian for the benefit of their minor children under the Uniform Gift to Minors Act. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or any other purpose.
- [F2]The shares subject to the option vest in three equal installments on September 17, 2008, September 17, 2009, and September 2010.